• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类过氧化物酶体增殖物激活受体的cDNA克隆、染色体定位及功能特性分析

cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor.

作者信息

Sher T, Yi H F, McBride O W, Gonzalez F J

机构信息

Laboratory of Molecular Carcinogenesis, National Cancer Institute, Bethesda, Maryland 20892.

出版信息

Biochemistry. 1993 Jun 1;32(21):5598-604. doi: 10.1021/bi00072a015.

DOI:10.1021/bi00072a015
PMID:7684926
Abstract

The human peroxisome proliferator activated receptor (hPPAR) was cloned from a human liver cDNA library. The cDNA exhibited 85% and 91% DNA and deduced amino acid sequence identity with mouse PPAR (mPPAR), respectively. The hPPAR gene was mapped on human chromosome 22 slightly telomeric to a linkage group of six genes and genetic markers that are located in the general region 22q12-q13.1. Cotransfection assays of mouse Hepa 1 cells were used to roughly compare the ability of hPPAR- and mPPAR-expressed cDNAs to trans-activate the acyl CoA oxidase (ACO) PPAR response element located 5' upstream to the minimal thymidine kinase promoter driving the expression of the chloramphenicol acetyl transferase (CAT) reporter gene. Both receptors elicited a response with the prototypical peroxisome proliferators nafenopin, clofibrate, and WY-14,643. Moreover, using cotransfection assays in which the CAT reporter plasmid contained the CYP4 A6 gene response element rather than the ACO element, it was shown that hPPAR is capable of very efficiently trans-activating a second PPAR response element. These results indicate that the PPAR is present in humans in a form that is functional and can trans-activate response elements derived from two different genes, the rat ACO and the rabbit CYP4A6.

摘要

人类过氧化物酶体增殖物激活受体(hPPAR)是从人类肝脏cDNA文库中克隆出来的。该cDNA与小鼠PPAR(mPPAR)的DNA和推导的氨基酸序列一致性分别为85%和91%。hPPAR基因定位于人类22号染色体上,略位于端粒方向,与位于22q12 - q13.1一般区域的六个基因和遗传标记的连锁群相邻。使用小鼠Hepa 1细胞的共转染试验来大致比较表达hPPAR和mPPAR的cDNA对位于驱动氯霉素乙酰转移酶(CAT)报告基因表达的最小胸苷激酶启动子5'上游的酰基辅酶A氧化酶(ACO)PPAR反应元件进行反式激活的能力。两种受体都对典型的过氧化物酶体增殖剂萘芬诺平、氯贝丁酯和WY - 14,643产生反应。此外,使用共转染试验,其中CAT报告质粒包含CYP4 A6基因反应元件而非ACO元件,结果表明hPPAR能够非常有效地反式激活第二个PPAR反应元件。这些结果表明,PPAR在人类中以一种功能性形式存在,并且能够反式激活源自两个不同基因(大鼠ACO和兔CYP4A6)的反应元件。

相似文献

1
cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor.人类过氧化物酶体增殖物激活受体的cDNA克隆、染色体定位及功能特性分析
Biochemistry. 1993 Jun 1;32(21):5598-604. doi: 10.1021/bi00072a015.
2
Characterization of a rabbit gene encoding a clofibrate-inducible fatty acid omega-hydroxylase: CYP4A6.
Arch Biochem Biophys. 1992 Jul;296(1):66-72. doi: 10.1016/0003-9861(92)90545-8.
3
Interaction of the peroxisome proliferator-activated receptor alpha with the retinoid X receptor alpha unmasks a cryptic peroxisome proliferator response element that overlaps an ARP-1-binding site in the CYP4A6 promoter.过氧化物酶体增殖物激活受体α与视黄酸X受体α的相互作用揭示了一个隐藏的过氧化物酶体增殖物反应元件,该元件与CYP4A6启动子中的ARP-1结合位点重叠。
J Biol Chem. 1994 Jul 8;269(27):18083-9.
4
The peroxisome proliferator-activated receptor mediates the induction of CYP4A6, a cytochrome P450 fatty acid omega-hydroxylase, by clofibric acid.过氧化物酶体增殖物激活受体介导氯贝酸对细胞色素P450脂肪酸ω-羟化酶CYP4A6的诱导作用。
J Biol Chem. 1992 Sep 25;267(27):19051-3.
5
A single amino acid change in the mouse peroxisome proliferator-activated receptor alpha alters transcriptional responses to peroxisome proliferators.小鼠过氧化物酶体增殖物激活受体α中的单个氨基酸变化改变了对过氧化物酶体增殖物的转录反应。
Mol Pharmacol. 1995 Sep;48(3):559-67.
6
The mouse peroxisome proliferator activated receptor recognizes a response element in the 5' flanking sequence of the rat acyl CoA oxidase gene.小鼠过氧化物酶体增殖物激活受体识别大鼠酰基辅酶A氧化酶基因5'侧翼序列中的一个反应元件。
EMBO J. 1992 Feb;11(2):433-9. doi: 10.1002/j.1460-2075.1992.tb05072.x.
7
Conserved amino acids in the ligand-binding and tau(i) domains of the peroxisome proliferator-activated receptor alpha are necessary for heterodimerization with RXR.过氧化物酶体增殖物激活受体α的配体结合域和tau(i)结构域中的保守氨基酸对于与视黄醇X受体的异源二聚化是必需的。
Mol Cell Endocrinol. 1999 Jan 25;147(1-2):37-47. doi: 10.1016/s0303-7207(98)00217-2.
8
Enantioselective activation of the peroxisome proliferator-activated receptor.过氧化物酶体增殖物激活受体的对映选择性激活
J Biol Chem. 1993 Mar 15;268(8):5530-4.
9
Comparison of dose-response relationships for induction of lipid metabolizing and growth regulatory genes by peroxisome proliferators in rat liver.过氧化物酶体增殖剂诱导大鼠肝脏脂质代谢和生长调节基因的剂量-反应关系比较。
Toxicol Appl Pharmacol. 1998 Aug;151(2):254-61. doi: 10.1006/taap.1998.8443.
10
Regulation of peroxisome proliferator-activated receptor-alpha mRNA in rat liver.大鼠肝脏中过氧化物酶体增殖物激活受体-α mRNA的调控
Arch Biochem Biophys. 1996 Feb 15;326(2):281-9. doi: 10.1006/abbi.1996.0077.

引用本文的文献

1
PPAR agonists for the treatment of cholestatic liver diseases: Over a decade of clinical progress.用于治疗胆汁淤积性肝病的过氧化物酶体增殖物激活受体激动剂:十年多的临床进展
Hepatol Commun. 2024 Dec 20;9(1). doi: 10.1097/HC9.0000000000000612. eCollection 2025 Jan 1.
2
The Versatile Role of Peroxisome Proliferator-Activated Receptors in Immune-Mediated Intestinal Diseases.过氧化物酶体增殖物激活受体在免疫介导的肠道疾病中的多功能作用。
Cells. 2024 Oct 12;13(20):1688. doi: 10.3390/cells13201688.
3
PPAR-Mediated Bile Acid Glucuronidation: Therapeutic Targets for the Treatment of Cholestatic Liver Diseases.
过氧化物酶体增殖物激活受体(PPAR)介导的胆汁酸葡萄糖醛酸化:胆汁淤积性肝病治疗的靶点。
Cells. 2024 Aug 1;13(15):1296. doi: 10.3390/cells13151296.
4
PPARs in Clinical Experimental Medicine after 35 Years of Worldwide Scientific Investigations and Medical Experiments.经过 35 年的全球科学研究和医学实验,PPARs 在临床实验医学中的应用。
Biomolecules. 2024 Jul 1;14(7):786. doi: 10.3390/biom14070786.
5
Identification of PPAR-related differentially expressed genes liver hepatocellular carcinoma and construction of a prognostic model based on data analysis and molecular docking.基于数据分析和分子对接鉴定与过氧化物酶体增殖物激活受体(PPAR)相关的肝癌差异表达基因并构建预后模型
J Cell Mol Med. 2024 Apr;28(8):e18304. doi: 10.1111/jcmm.18304.
6
pparβ regulates lipid catabolism by mediating acox and cpt-1 genes in Scophthalmus maximus under heat stress.过氧化物酶体增殖物激活受体 β 通过介导热应激下大黄鱼的 acox 和 cpt-1 基因调控脂质分解代谢。
Fish Physiol Biochem. 2024 Feb;50(1):295-305. doi: 10.1007/s10695-024-01313-w. Epub 2024 Feb 22.
7
Non-coding RNAs as Key Regulators of the Notch Signaling Pathway in Glioblastoma: Diagnostic, Prognostic, and Therapeutic Targets.非编码 RNA 作为胶质母细胞瘤 Notch 信号通路的关键调控因子:诊断、预后和治疗靶点。
CNS Neurol Disord Drug Targets. 2024;23(10):1203-1216. doi: 10.2174/0118715273277458231213063147.
8
Integrated Transcriptomics and Metabolomics Reveal Changes in Cell Homeostasis and Energy Metabolism in in Response to Acute Hypoxic Stress.整合转录组学和代谢组学揭示急性低氧应激下细胞内稳态和能量代谢的变化。
Int J Mol Sci. 2024 Jan 15;25(2):1054. doi: 10.3390/ijms25021054.
9
Accumulation of Linoleic Acid by Altered Peroxisome Proliferator-Activated Receptor-α Signaling Is Associated with Age-Dependent Hepatocarcinogenesis in Transgenic Mice.过氧化物酶体增殖物激活受体-α信号改变导致亚油酸蓄积与转基因小鼠年龄依赖性肝癌发生相关。
Metabolites. 2023 Aug 10;13(8):936. doi: 10.3390/metabo13080936.
10
Peroxisome proliferator-activated receptors as targets to treat metabolic diseases: Focus on the adipose tissue, liver, and pancreas.过氧化物酶体增殖物激活受体作为治疗代谢性疾病的靶点:聚焦脂肪组织、肝脏和胰腺。
World J Gastroenterol. 2023 Jul 14;29(26):4136-4155. doi: 10.3748/wjg.v29.i26.4136.